"The
Report N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or
FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4
Receptor or RFP or FPR2) - Pipeline Review, H1 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
N-Formyl
Peptide Receptor 2 (FMLP-Related
Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or
Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2016,
provides in depth analysis on N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) targeted pipeline
therapeutics.
The report provides
comprehensive information on the N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2), targeted
therapeutics, complete with analysis by indications, stage of
development, mechanism of action (MoA), route of administration (RoA)
and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally,
the report provides an overview of key players involved in N-Formyl
Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl
Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or
FPR2) targeted therapeutics development and features dormant and
discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/735288
Scope
- The report provides a
snapshot of the global therapeutic landscape for N-Formyl Peptide
Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide
Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2)
- The report reviews N-Formyl
Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl
Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or
FPR2) targeted therapeutics under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved in N-Formyl Peptide Receptor 2 (FMLP-Related
Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or
Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics and enlists
all their major and minor projects
- The report assesses N-Formyl
Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl
Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or
FPR2) targeted therapeutics based on mechanism of action (MoA), route
of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news and deals related to N-Formyl Peptide Receptor 2 (FMLP-Related
Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or
Lipoxin A4 Receptor or RFP or FPR2) targeted therapeutics
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand the
targeted therapy areas and indications for N-Formyl Peptide Receptor
2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide
Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2)
- Identify the use of drugs for
target identification and drug repurposing
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) development
landscape
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Overview 6
Therapeutics Development 7
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Products under
Development by Stage of Development 7
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Products under
Development by Therapy Area 8
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Products under
Development by Indication 9
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Products
Glance 10
Early Stage Products 10
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Products under
Development by Companies 11
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Products under
Development by Universities/Institutes 13
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Therapeutics
Assessment 15
Assessment by
Monotherapy/Combination Products 15
Assessment by Mechanism of
Action 16
Assessment by Molecule Type 18
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Companies Involved
in Therapeutics Development 20
Bristol-Myers Squibb Company 20
CohBar, Inc. 21
Polyphor Ltd. 22
N-Formyl Peptide Receptor 2
(FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like
1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Drug Profiles 23
Drugs to Agonize FPR-2 for
Inflammation - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Humanin - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
NCP-70X - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment